Hématologie

Flash presse - 1er trimestre 2024

Lin-Pierre ZHAO · 7 mars 2024 · Mars 2024

Letermovir en prophylaxie post-greffe : combien de temps ? Russo D, Schmitt M, Pilorge S, Stelljes M, Kawakita T, Teal VL, et al. Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Haematol. 2024 ; 1(2):e127-e135. doi: